
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).
Fecha de publicación: 6 de septiembre de 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2...
Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps. VER MÁS
Phage Display Libraries for Antibody Therapeutic Discovery and Development. VER MÁS
Fecha de publicación: 6 de octubre de 2021 Increased survival in puppies affected by Canine Parvovirus type II using...
Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons. VER MÁS
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS
Fecha de publicación: 16 mayo de 2019 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract Transferon®) Ver...
Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI